Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)-Reference-Cited by-同舟云学术

Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)

Published:2022-01 Issue:1 Volume:13 Page:82-87
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Koga Futa,Kawaguchi Yasunori,Shimokawa Mototsugu,Murayama Kenichiro,Nakashita Shunya,Oza Noriko,Ureshino Norio,Takahashi Hirokazu,Ueda Yujiro,Nakazawa Junichi,Komori Azusa,Otsu Satoshi,Arima Shiho,Fukahori Masaru,Makiyama Akitaka,Taguchi Hiroki,Honda Takuya,Shibuki Taro,Nio Kenta,Ide Yasushi,Mizuta Toshihiko,Shirakawa Tsuyoshi,Otsuka Taiga,Mitsugi Kenji

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Epidemiology of pancreatic cancer;Ilic;World J Gastroenterol,2016

3. Management of Cancer in the older person: a practical approach;Balducci;Oncologist,2000

4. Management of pancreatic cancer in the elderly;Higuera;World J Gastroenterol,2016

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel;Scientific Reports;2024-07-23

2. Efficacy and Toxicity of Palliative Chemotherapy in Elderly Patients With Advanced Pancreatic Cancer;Pancreas;2024-02-02

3. Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel;2023-11-29

4. Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study;International Journal of Clinical Oncology;2023-11-22

5. Enhanced mitochondrial co-localization of β-escin micelle and pancreatic tumor accumulation relation;Journal of Drug Delivery Science and Technology;2023-11